Animal-free antibody webinar series
Join us on July 23 to learn more about how animal-free recombinant antibodies (rAbs) are being used to fight diseases, such as Covid-19.
Sequence-defined rAbs have numerous scientific benefits over undefined, animal-derived antibodies, including higher affinity and specificity, faster generation time, and reduced immunogenicity. The US National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), the PETA International Science Consortium Ltd., and the European Union Reference Laboratory for alternatives to animal testing (EURL ECVAM), are organizing a free webinar series in which experts will address the applications and benefits of rAbs, including in assays, biosensors, drug manufacturing, diagnostics, and therapeutic products.
In the first webinar, you will hear from experts about the use of animal-free rAbs to develop life-saving vaccines and treatments.
- Dr Stefan Dübel (Technische Universität Braunschweig) will describe his work developing fully human antibodies against infections, such as Covid-19 and diphtheria.
- Dr Sachdev Sidhu (Toronto Recombinant Antibody Centre) will describe his successes at the Toronto Recombinant Antibody Centre, particularly related to developing non-animal antibodies against the coronavirus SARS-CoV-2.
Date: July 23, 2020
Time: 10:00–11:00 am EDT (4:00–5:00 pm CEST)